Germline mutation in PTEN, canonically a tumor suppressor gene, is the molecular criterion for the diagnosis of PTEN Hamartoma Tumor Syndrome (PHTS), an autosomal dominant cancer predisposition syndrome where individuals present variably. The gene discussed is PTEN; the disease is PTEN hamartoma tumor syndrome.